- This event has passed.
Cardiovascular Grand Rounds: Craig R. Lee, PharmD, PhD, Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention
November 6, 2017 @ 12:00 pm - 1:00 pm
Speaker: Craig R. Lee, Pharm.D., Ph.D., FCCP, FAHA. Associate Professor of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy
Topic: Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention
Comments are closed.